T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair (Q26746255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

review article

1 reference

title

T3/TRs axis in hepatocellular carcinoma: new concepts for an old pair (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

main subject

hepatocellular carcinoma

1 reference

Michelina Plateroti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

language of work or name

English

0 references

publication date

27 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

published in

Endocrine-Related Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

R353-69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma

16 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Identification of driver genes in hepatocellular carcinoma by exome sequencing

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Tri-iodothyronine induces hepatocyte proliferation by protein kinase A-dependent β-catenin activation in rodents.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Emerging trends in hepatocellular carcinoma incidence and mortality

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

A thyroid hormone receptor/KLF9 axis in human hepatocytes and pluripotent stem cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Triiodothyronine accelerates differentiation of rat liver progenitor cells into hepatocytes

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Tri-iodothyronine enhances liver regeneration after living donor liver transplantation in rats

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Targeting thyroid hormone receptor beta in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Pancreatic cancer and medical history in a population-based case-control study in the San Francisco Bay Area, California

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Untranslated regions of thyroid hormone receptor beta 1 mRNA are impaired in human clear cell renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Aberrant methylation of the THRB gene in tissue and plasma of breast cancer patients.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone inhibits TGFβ1 induced renal tubular epithelial to mesenchymal transition by increasing miR34a expression

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

microRNA-1274a, a modulator of sorafenib induced a disintegrin and metalloproteinase 9 (ADAM9) down-regulation in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality?

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Regulatory feedback loop between T3 and microRNAs in renal cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyromimetics: a journey from bench to bed-side

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor gene knockouts.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Tissue-specific actions of thyroid hormone: insights from animal models

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The microcosmos of cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MicroRNA signatures in human cancers

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Nongenomic actions of thyroid hormone.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptors are tumor suppressors in a mouse model of metastatic follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The molecular basis of thyroid hormone action

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Gaining ligand selectivity in thyroid hormone receptors via entropy

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Autoregulatory loop of nuclear corepressor 1 expression controls invasion, tumor growth, and metastasis

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Basic transcription element-binding protein (BTEB) is a thyroid hormone-regulated gene in the developing central nervous system. Evidence for a role in neurite outgrowth.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of the thyroid hormone receptor, the oncogenes c-myc and H-ras, and the 90 kD heat shock protein in normal, hyperplastic, and neoplastic human thyroid tissue

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Functions of thyroid hormone receptors in mice

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone regulates endogenous amyloid-beta precursor protein gene expression and processing in both in vitro and in vivo models

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone analogues: where do we stand in 2013?

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3).

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Exogenous thyroid hormone induces liver enlargement, whilst maintaining regenerative potential--a study relevant to donor preconditioning

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Physiological and molecular basis of thyroid hormone action

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Tri-Iodothyronine as a Stimulator of Liver Regeneration after Partial and Subtotal Hepatectomy

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The Impact of a Non-Functional Thyroid Receptor Beta upon Triiodotironine-Induced Cardiac Hypertrophy in Mice

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of the ErbA-beta class of thyroid hormone receptors is selectively lost in human colon carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Role of Kruppel-like factors in leukocyte development, function, and disease

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The rat thyroid hormone receptor (TR) Deltabeta3 displays cell-, TR isoform-, and thyroid hormone response element-specific actions

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Minireview: Pathophysiological importance of thyroid hormone transporters

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Reactivation of the silenced thyroid hormone receptor β gene expression delays thyroid tumor progression

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Molecular aspects of thyroid hormone actions

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Expression of TRbeta1 mRNAs with functionally impaired mutations is rare in thyroid papillary carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC)

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Isoform-specific transcriptional regulation by thyroid hormone receptors: hormone-independent activation operates through a steroid receptor mode of co-activator interaction

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Aberrant Alternative Splicing of Thyroid Hormone Receptor in a TSH-Secreting Pituitary Tumor Is A Mechanism for Hormone Resistance

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Patterns of liver gene expression governed by TRbeta

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

The thyroid hormone nuclear receptor TRα1 controls the Notch signaling pathway and cell fate in murine intestine

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Epigenetic inactivation of the thyroid hormone receptor beta1 gene at 3p24.2 in lung cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

MiR-224 targets the 3'UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Epigenetic regulation of thyroid hormone receptor beta in renal cancer.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Epigenetic analysis of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Astrocyte elevated gene-1 overexpression in hepatocellular carcinoma: an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1530%2FERC-16-0152

7 January 2021

Identifiers

DOI

10.1530/ERC-16-0152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27353037%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference